Virax Biolabs Group Ltd (VRAX) stock
VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
$0.45−0.00 (-0.65%)
Close on Nov 17, 2026Market cap $257.81KP/E –Yield –
Virax Biolabs market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Virax Biolabs's market cap was $363.23K on Nov 11, 2026, against $1.75M a year earlier. Over the last 4 years it ranged from $363.23K to $53.87M, with a median of $3.44M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $363.23K | -75.8% |
| 2025 | Dec 31, 2025 | $1.50M | -74.1% |
| 2024 | Dec 31, 2024 | $5.79M | +155.1% |
| 2023 | Dec 29, 2023 | $2.27M | -68.8% |
| 2022 | Dec 30, 2022 | $7.28M | – |
See a number that looks wrong?